Methylprednisolone is a prednisolone derivative glucocorticoid with higher potency than prednisone. It was first described in the literature in the late 1950s.
...
Oral and intramuscular methylprednisolone are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, nervous system, and other disorders. Intra-articular and soft tissue injections are indicated for short term treatment of acute gouty arthritis, acute an...
University of Utah Orthopaedic Center, Salt Lake City, Utah, United States
UConn Health, Farmington, Connecticut, United States
Leiden University Medical Centre, Leiden, Zuid Holland, Netherlands
Outpatient Care Center, Chicago, Illinois, United States
Institute of Sports Medicine Copenhagen, Bispebjerg Hospital, Kobenhavn, Denmark
The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
Hamilton General Hospital, Hamilton, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.